Standout Papers

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma 2017 2026 2020 2023 654
  1. Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma (2017)
    Thomas Powles, Peter H. O’Donnell et al. JAMA Oncology

Citation Impact

2 by Nobel laureates 15 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction of broken DNA ends
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
3 intermediate papers

Works of Michael Ong being referenced

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
2017 Standout
Appraising iniparib, the PARP inhibitor that never was—what must we learn?
2013
and 1 more

Author Peers

Author Oncology PRM Cancer Research Surgery Last Decade Papers Cites
Michael Ong 1114 439 152 554 87 1.7k
Jenny Chung-Yee Ho 24 20 17 80 13 515
C. D. Wheeler 9 130
Paola Verdecchia 12 6 3 49 16 278
Lars D. Maerz 34 12 35 14 10 373
Sudha Rao 26 23 55 28 4 644

All Works

Loading papers...

Rankless by CCL
2026